The latest closing stock price for Entrada Therapeutics as of March 03, 2025 is 11.33.
An investor who bought $1,000 worth of Entrada Therapeutics stock at the IPO in 2021 would have $-527 today, roughly -1 times their original investment - a -22.08% compound annual growth rate over 3 years.
The all-time high Entrada Therapeutics stock closing price was 35.00 on November 17, 2021.
The Entrada Therapeutics 52-week high stock price is 21.79, which is 92.3% above the current share price.
The Entrada Therapeutics 52-week low stock price is 11.28, which is 0.4% below the current share price.
The average Entrada Therapeutics stock price for the last 52 weeks is 15.41.
An investor who bought $1,000 worth of Entrada Therapeutics stock at the IPO in 2021 would have $-527 today, roughly -1 times their original investment - a -22.08% compound annual growth rate over 3 years.
The all-time high Entrada Therapeutics stock closing price was 35.00 on November 17, 2021.
The Entrada Therapeutics 52-week high stock price is 21.79, which is 92.3% above the current share price.
The Entrada Therapeutics 52-week low stock price is 11.28, which is 0.4% below the current share price.
The average Entrada Therapeutics stock price for the last 52 weeks is 15.41.